A Study on Challenges in Cross Border Merger and Acquisition vis-a-vis Daiichi-Ranbaxy-Fortis healthcare deal

  • Khyati Jain and Dr. Qazi Mohammed Usman
  • Show Author Details
  • Khyati Jain

    Research Scholar at Jamia Millia Islamia, New Delhi, India

  • Dr. Qazi Mohammed Usman

    Professor at Jamia Millia Islamia, New Delhi, India

  • img Download Full Paper


In India, incidences of cross-border mergers and acquisitions have significantly increased over the past three decades. When it came to cross-border transactions, the Indian economy was not particularly friendly, either before or after independence. In terms of these transactions, India has experienced a huge transformation especially with the introduction of liberalization policy in 1991, which has opened doors of Indian economy for the rest of the world. It is currently one of the most often used restructuring methods worldwide as it comes with various advantages for foreign countries and host country as well. These days, all countries in the world—not just India—have a substantial interest in executing cross-border deals. But, in India, even with so many groundbreaking regulations, such as the Foreign Exchange Management Act of 1999, Sec 234 of The Companies Act, 2013, Cross Border merger rules, considerable criticism to these deals still arises from the restricted government policies, inadequate due diligence, taxation issues, complex legal procedures and many more. In this paper, the author has examined the history and evolution of cross-border regulations and cases. It mostly focused on difficulties arosed from the inadequate due diligence from these deals. The author has also analyzed well-known cases of inbound merger and acquisitions in India, like the Daichi -Ranbaxy- Sun Pharma and Fortis- IHH Berhad, Malaysia deal. It additionally addresses the lessons learned by India from the past deals as well as potential solutions for it.


Research Paper


International Journal of Law Management and Humanities, Volume 7, Issue 2, Page 112 - 124

DOI: https://doij.org/10.10000/IJLMH.117001

Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution -NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting, and building upon the work for non-commercial use, provided the original work is properly cited.


Copyright © IJLMH 2021